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 ABSTRACT 
 The objective of this study was to evaluate the effect 
of supplementation with oral Ca boluses after calving 
on early-lactation health and milk yield. Cows in their 
second lactation or greater (n = 927) from 2 large dair-
ies in Wisconsin were enrolled during the summer of 
2010. Both herds were fed supplemental anions during 
the prefresh period and less than 1% of fresh cows were 
treated for clinical milk fever. Cows were scored before 
calving for lameness and body condition, and then 
randomly assigned to either a control group or an oral 
Ca bolus-supplemented group. Control cows received 
no oral Ca boluses around calving. Cows in the oral 
Ca bolus group received 2 oral Ca boluses (Bovikalc, 
Boehringer Ingelheim, St. Joseph, MO), one bolus 0 to 
2 h after calving and the second 8 to 35 h after calv-
ing. The oral Ca bolus administration schedule allowed 
fresh cows to be restrained in headlocks only once daily. 
Whole-blood samples were collected immediately before 
the second oral Ca bolus was given and were analyzed 
for ionized Ca (Ca2+) concentration. Early-lactation 
health events were recorded and summed for each cow. 
Only 6 cases (0.6% of calvings) of clinical milk fever 
occurred during the trial, and only 14% of cows tested 
were hypocalcemic (Ca2+ less than 1.0 mmol/L) at 8 
to 35 h after calving. Mean Ca2+ concentrations were 
not different between the control and oral Ca bolus-
supplemented groups. Blood samples from the cows 
given oral Ca boluses were collected an average of 20.6 
h after administration of the first bolus. Subpopula-
tions of cows with significant responses to oral Ca bolus 
supplementation were identified based on significant in-
teractions between oral Ca bolus supplementation and 
covariates in mixed multiple regression models. Lame 
cows supplemented with oral Ca boluses averaged 0.34 
fewer health events in the first 30 d in milk compared 
with lame cows that were not supplemented with oral 
Ca boluses. Cows with a higher previous lactation 
mature-equivalent milk production (greater than 105% 
of herd rank) and supplemented with oral Ca boluses 
produced 2.9 kg more milk at their first test after calv-
ing compared with cows with higher previous lactation 
milk yields that were not supplemented. Results of this 
study indicate that lame cows and higher producing 
cows responded favorably to supplementation with oral 
Ca boluses. Supplementing targeted subpopulations of 
cows with oral Ca boluses was beneficial even for dair-
ies with a very low incidence of hypocalcemia. 
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 INTRODUCTION 
 Milk fever (parturient hypocalcemia) is an important 
metabolic disorder of dairy cattle around the time 
of calving. The mean incidence of clinical milk fever 
in published field studies was about 3.5% for North 
American and Australasian studies and about 6.2% for 
European studies (DeGaris and Lean, 2008). About 
50% of cows in their second lactation and greater have 
blood Ca concentrations that fall below the threshold 
for subclinical hypocalcemia after calving (Reinhardt et 
al., 2011). Hypocalcemia may lead to reduced feed in-
take, poor rumen and intestine motility, increased risk 
of displaced abomasum, reduced milk yield, increased 
susceptibility to infectious diseases, and increased risk 
of early-lactation removal from the herd (Curtis et al., 
1983; Goff, 2008; Seifi et al., 2011). Mechanisms that 
may explain the detrimental effects of hypocalcemia 
include impaired energy balance, which is reflected in 
higher serum NEFA concentrations (Reinhardt et al., 
2011), and direct impairment of immune cell responses 
to an activating stimulus (Kimura et al., 2006). 
 Identification of cows with subclinical hypocalcemia 
is impractical because these cows, by definition, do 
not display overt clinical signs. Thus, prevention is the 
only option for managing subclinical hypocalcemia. 
One prevention strategy is to supplement anions before 
calving. Charbonneau et al. (2006) conducted a large 
meta-analysis of previously published studies and de-
termined that feeding a typical dose of anions before 
calving results in a 5-fold reduction in the risk of clini-
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cal milk fever. Fewer studies have evaluated the effect 
of anion supplementation on subclinical hypocalcemia. 
Beede et al. (1992) reported that feeding anionic salts 
before calving in a large field study (n = 510 cows, all 
parities) reduced the subclinical hypocalcemia (defined 
as Ca2+ ≤1.00 mmol/L on the day of calving) from 
50% in the control cows to 19% in the cows receiving 
the anionic salts. Other, smaller studies have shown 
similar reductions in subclinical hypocalcemia when 
anions were supplemented (Oetzel et al., 1988) or have 
shown smaller numerical reductions in the incidence 
of subclinical hypocalcemia that were not statistically 
significant (Goff and Horst, 1997; Ramos-Nieves et al., 
2009).
Another approach to prevention of subclinical hypo-
calcemia is oral Ca supplementation around calving. 
Calcium chloride may be particularly beneficial as an 
oral supplement because it provides highly available 
oral Ca (Goff and Horst, 1993, 1994) and because it is 
a more potent acidifier than other anion sources (Goff 
et al., 2004; Gelfert et al., 2010). Systemic acidifica-
tion has been associated with beneficial effects on Ca 
metabolism beyond the expected contribution of Ca ab-
sorbed from the gastrointestinal tract. The underlying 
mechanism for the benefits of systemic acidification is 
the correction of metabolic alkalosis, which blunts the 
response of the cow to parathyroid hormone (Goff et 
al., 1991; Phillippo and Reid, 1994; Goff, 2008).
Thilsing-Hansen et al. (2002) summarized oral Ca 
supplementation trials and found oral Ca from a vari-
ety of formulations to be consistently beneficial. Using 
oral CaCl2 as the source of oral Ca has been shown to 
increase blood Ca concentrations, reduce the risk of 
clinical and subclinical hypocalcemia, and reduce the 
risk of displaced abomasum (Oetzel, 1996; Dhiman and 
Sasidharan, 1999). However, CaCl2 may be caustic to 
the oral mucosa, and large, repeated doses could induce 
uncompensated metabolic acidosis, especially if the cow 
is already being fed an acidogenic diet (Goff and Horst, 
1993).
The effect of oral Ca supplementation in cows that 
have received an acidogenic diet before calving has 
been minimally studied. Melendez et al. (2002) evalu-
ated oral CaCl2 in a herd fed anionic salts and found 
no effect of oral Ca supplementation on Ca2+ at 24 
h postcalving. The authors concluded that oral Ca 
supplementation around calving may not be necessary 
when negative DCAD diets are fed. However, relatively 
few cows were enrolled in this study (30 control cows 
and 30 cows supplemented with oral CaCl2), and it was 
not possible to identify subpopulations of cows that 
may have responded well to the oral CaCl2 supplemen-
tation. Neither milk yield nor cow health was evaluated 
in this study.
Calcium chloride, in combination with CaSO4, has 
been formulated into a solid bolus coated with fat 
(Bovikalc, Boehringer Ingelheim Vetmedica Inc., St. 
Joseph, MO). One bolus provides 43 g of Ca (71% from 
CaCl2 and 29% from CaSO4). Compared with oral Ca 
gel formulations, the bolus has the advantages of pro-
tecting the cow from the sharp taste of the CaCl2 and 
eliminating the risk of aspiration pneumonia (Pehrson 
and Jonsson, 1991). In a 2-part field study, Pehrson and 
Jonsson (1991) gave 4 total oral Ca boluses (1 before 
calving, 1 at calving, and 2 after calving) and reported 
that the boluses reduced the risk of clinical milk fever 
4-fold compared with that of cows administered a pla-
cebo bolus. They concluded that the oral Ca boluses 
were at least as effective as a CaCl2 gel in preventing 
clinical milk fever and that the more sustained release 
of Ca from the bolus formulation could be responsible 
for its beneficial effects.
Sampson et al. (2009) supplemented multiparous 
cows (n = 20) with 2 oral Ca boluses after calving. They 
reported significantly increased Ca2+ concentrations 1 
h after administration of the first oral Ca bolus (which 
was given at calving) and 1 h after administration of 
the second bolus (which was given 12 h after calving). 
Urinary pH was significantly reduced from about 8.0 
to 6.8 in cows given the oral Ca boluses; the authors 
concluded that acidification likely contributed to the 
ability of the boluses to support blood Ca2+ concentra-
tions after calving. No larger scale studies have been 
conducted with oral Ca boluses, and no studies have 
evaluated milk production or cow health outcomes.
The objectives of this study were to conduct a large 
field study in commercial dairy herds with effective 
anionic salt feeding programs already in place 1) to 
evaluate the effects of supplementation with an oral Ca 
bolus containing CaCl2 and CaSO4 on detailed mea-
sures of early-lactation health and milk yield and 2) to 
determine whether groups of cows could be identified 
within these herds that have significantly different re-
sponses to oral Ca bolus supplementation.
MATERIALS AND METHODS
Study Population
The study was conducted on 2 large commercial dairy 
farms in Wisconsin during the summer of 2010. To be 
selected for the study, the herds had to meet the follow-
ing criteria: milk at least 1,500 cows, have headlocks in 
the prefresh and postfresh cow pens, use Dairy Comp 
305 (Valley Agricultural Software, Tulare, CA) records 
for on-farm management, be willing to administer the 
boluses according to the project protocol, and be will-
ing to collect and properly handle whole-blood samples 
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after calving. A description of the study herds has been 
published previously (McArt et al., 2011). Herd A in 
the current study corresponds to herd C in the previous 
description, and herd B in the current study corresponds 
to herd D. A more detailed description of typical diets 
fed to the herds during the trial is presented in Table 
1. Herd A contributed 327 cows (40% of total cows) to 
the study, and herd B contributed 555 cows (60% of 
total cows). Both cooperating dairies signed a consent 
form agreeing to the project protocol and were given 
a document containing information on disease defini-
tions used in the trial. The study protocol was reviewed 
and approved by the University of Wisconsin–Madison 
School of Veterinary Medicine Animal Care and Use 
Committee (No. V01479-0-05-10).
Cows were randomly assigned to either the control or 
oral Ca bolus group before calving. A random number 
generator was used to determine the treatment assign-
ment for the first cow enrolled; remaining treatment 
assignments were made sequentially (every other cow). 
Treatment assignments were indicated by color-coded 
neck chain tags placed on the cows.
At the same time the cows were assigned to treat-
ment, they were also evaluated for locomotion score 
and BCS. Locomotion score was determined using the 
1- to 4-point scoring system described by Nordlund et 
al. (2004), in which cows were categorized as nonlame 
(score 1), slightly lame, moderately lame, or severely 
lame (score 4). Prefresh BCS was determined using a 1- 
to 5-point scoring system with 0.25-unit increments as 
described by Ferguson et al. (1994), in which a higher 
score represents a greater body condition. Two trained 
evaluators assigned all the prefresh scores, with 1 evalu-
ator assigning each locomotion score and 1 evaluator 
assigning each BCS. Scores were taken an average of 
15.6 d (±0.3 SEM) before calving.
Cows were enrolled in the study immediately after 
calving; prefresh data were collected from some cows 
that did not meet the final criteria for enrollment. Cows 
in the control group received no oral Ca boluses after 
calving, and cows in the oral Ca bolus group received 
2 boluses. The first bolus was administered within 2 h 
after calving. The second bolus was given when the cow 
was next locked up in the postfresh pen after calving 
Table 1. Summary of formulated feed ingredient amounts and formulated nutrient composition of example 
diets fed on 2 commercial dairies to the pre- and postfresh cows during the study 
Feed ingredient or nutrient
Herd A Herd B
Prefresh Postfresh Prefresh Postfresh
Ingredient, % of DM      
 Alfalfa hay 13.0 9.8  — —
 Alfalfa silage — 17.4  7.1 24.5
 Corn silage 29.8 36.5  16.3 41.6
 Grass hay 14.0 —  10.7 —
 Wheat straw 14.0 2.2  22.7 —
 Ground corn — 8.7  13.3 1.9
 Whey permeate — 2.2  — —
 Corn gluten feed (dry) — 8.5  10.7 6.5
 Corn distillers grains (dry) — —  9.2 8.8
 Corn distillers grains (wet) — —  — 2.3
 Brewers grains (wet) — —  7.1 6.5
 Prefresh concentrate mix 29.2 —  2.9 —
 Postfresh concentrate mix — 14.8  — 7.9
 DM, %, as fed 45.2 43.0  59.0 41.5
Nutrient composition (DM basis)      
 CP, % 13.7 17.2  15.0 17.5
 Ether extract, % 3.5 4.7  4.3 4.9
 NDF, % 44.3 30.3  43.1 33.5
 Starch, % 14.8 19.8  19.6 21.8
 NFC,1 % 30.5 39.3  29.4 36.0
 Ash, % 8.04 8.50  8.23 8.10
 Ca, % 0.93 0.92  0.88 0.79
 P, % 0.34 0.43  0.41 0.44
 Mg, % 0.39 0.37  0.34 0.37
 Na, % 0.09 0.48  0.14 0.46
 K, % 1.08 1.54  1.27 1.44
 Cl, % 0.73 0.58  0.88 0.45
 S, % 0.35 0.25  0.25 0.25
 DCAD,2 mEq/kg −109 283  −18 285
1Calculated as 100 − CP − ether extract − NDF − ash.
2Calculated as mEq [(Na + K) − (Cl + S)].
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and had to be administered between 8 to 35 h after 
calving. If the cow reached the postfresh pen before 8 
h postcalving, she was given her second bolus the next 
day. The bolus administration schedule was chosen to 
fit within the normal management activities of large 
dairies, and it required cows to be restrained in head-
locks only once daily. The schedule was also chosen to 
include the time period cows are expected to be experi-
encing the most profound hypocalcemia, which is about 
12 to 24 h postcalving (Goff, 2008; Ramos-Nieves et al., 
2009). The mean time between calving and administra-
tion of the second bolus was 20.6 h (±0.2 SEM).
In total, 1,780 calvings occurred during the study pe-
riod; 1,127 of these involved cows in their second lacta-
tion or greater. To be eligible for the trial, multiparous 
cows needed valid on-farm record information, could 
not start the lactation with an abortion (defined as 
gestation length <260 d), could not have a calving ease 
score of 5 (indicative of a C-section or fetotomy), had 
to remain in the herd until at least 2 DIM, had to have 
been randomly assigned to treatment before calving, 
and (for cows assigned to the oral Ca bolus group) had 
to receive both of the boluses within the specified time 
periods. Of the 1,127 possible cows, 927 were entered 
into the trial and 200 were excluded. Table 2 presents a 
summary description of cows excluded from the study.
Of the 927 cows enrolled, 431 were in the oral Ca 
bolus group and 496 were in the control group. The 
slight imbalance occurred because more of the cows 
initially assigned to the oral Ca bolus group were ex-
cluded from the study. More criteria had to be met for 
a cow to fulfill the requirements for being in the oral 
Ca bolus group (i.e., correct bolus administration both 
times) compared with the very minimal requirements 
for inclusion in the control group.
Study Outcomes
Whole-blood samples were collected for Ca2+ analysis 
at 8 to 35 h after calving. Between 1 and 3 mL of 
whole blood was collected from the coccygeal vein or 
artery into syringes containing dry Li heparin (Portex 
Pro-Vent Plus; Smith’s Medical, New York, NY). After 
collection, air was excluded from the syringes using the 
filter tip provided, and the syringes were refrigerated 
within 30 m. A portable blood analyzer (VetStat Elec-
trolyte and Blood Gas Analyzer; Idexx Laboratories, 
Westbrook, ME) was used to measure Ca2+. Whole 
blood from the syringes was analyzed for Ca2+ con-
centration within 72 h of collection (average time from 
collection to analysis was 28.1 ± 0.6 h (SEM). This 
storage and sampling protocol was validated by collect-
ing a blood sample from 16 parturient cows into dry Li 
heparin syringes and measuring the Ca2+ concentration 
from this syringe at 0, 24, 48, and 72 h after collection. 
The mean concentration of Ca2+ changed minimally 
(0.01 mmol/L) after 72 h of storage.
The Ca2+ results from the portable analyzer were 
validated by comparing them with in-house laboratory 
results. Ionized Ca result samples collected from 20 
parturient cows were analyzed on both the portable 
analyzer and on an in-house blood gas plus Ca2+ ana-
lyzer (Nova Stat Profile pHOx Plus; Nova Biomedical 
Corp., Waltham, MA). Results were compared by lin-
ear regression, and agreement between the 2 different 
analyzers was excellent (R2 = 0.92). The difference 
between intercepts for the 2 different analyzers was 
corrected by adding 0.09 mmol/L to each Ca2+ result 
from the portable analyzer.
Whole-blood BHBA concentration was determined 6 
times for each cow between 3 and 16 DIM on Mon-
days, Wednesdays, and Fridays using a handheld me-
ter (Precision Xtra; Abbott Diabetes Care, Alameda, 
CA). Iwersen et al. (2009) reported that this meter has 
excellent agreement with laboratory analysis of serum 
for BHBA (R2 = 0.90). Ketosis was defined as BHBA 
≥1.2 mmol/L on any BHBA test (McArt et al., 2011). 
Cows were required to have 5 or 6 negative BHBA tests 
before they were classified as negative for ketosis.
First-test daily milk weights came either from DHI 
test weights (herd A) or from daily milk weights col-
lected by the parlor meters (herd B). About 8% of the 
parlor milking weights were missing for herd B. To min-
imize the number of missing first-test-day milk weights 
that would result from a cow missing any one of her 3 
milking weights on test day, missing milk weights were 
imputed using a method based on hot-deck imputation. 
A randomly selected milking weight from 1 of the 5 
milking weights before or after the missing weight was 
used to fill in the missing value. A milking weight was 
not imputed (i.e., it was left as a missing value) if the 
10 milking weights around it were all missing as well.
Early-lactation health outcomes recorded were metri-
tis, ketosis, displaced abomasum, mastitis, pneumonia, 
herd removal, or death. Clinical milk fever, hypocalce-
mia (defined as blood Ca2+ ≤1.00 mmol/L at 8 to 35 h 
Table 2. Reasons for excluding cows from the trial1 
Reason Cows, n
Invalid record information 4
Aborted (<260-d gestation length) 31
Calving ease score of 5 (C-section or fetotomy) 1
Removed before 2 DIM 9
Calved without random treatment assignment (no tag) 69
Received the first oral Ca bolus but not the second 85
Received the second oral Ca bolus but not the first 1
1Experimental cows were selected from multiparous cows that calved 
during a 3-mo time period on 2 commercial dairies.
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after calving), and retained placenta were summarized 
but not evaluated statistically because they could be di-
agnosed before both oral Ca boluses were administered. 
Health events were considered only if they occurred 
in the first 30 DIM. Health outcomes were recorded 
by the cooperating dairy producers. Early-lactation 
cow health was analyzed as individual events and as a 
single, continuous variable that represented the sum of 
individual health events during the first 30 DIM. Up to 
6 events per cow were possible; the actual range was 0 
to 4 events per cow.
Other study outcomes included postfresh locomo-
tion score, postfresh BCS, and reproduction outcomes 
[first-service conception, pregnancy by 150 DIM, days 
open for cows pregnant by 150 DIM, and days from the 
voluntary waiting period (VWP) to conception by 305 
DIM]. Postfresh locomotion and BCS were determined 
between 40 and 60 DIM by using the same methods as 
described before, with the addition of a third trained 
evaluator who assigned about 65% of the postfresh 
scores.
Study Covariates
Covariates for early-lactation outcomes were factors 
that could be known about the cow at the time of 
calving. These included parity, prefresh locomotion 
score, prefresh BCS, twin calves or a single birth, a 
stillborn or live calf, previous gestation length (i.e., 
length of the gestation preceding enrollment in the 
study), previous lactation length, previous dry period 
length, and calving ease score (1 to 5 scale, with 1 
representing no calving assistance and 5 representing 
extreme assistance). The time interval between calv-
ing and blood sample collection was included as an 
additional covariate for the Ca2+ analysis, DIM at the 
first DHI test was included as an additional covariate 
for the first test milk yield analysis, and DIM at scor-
ing was included as an additional covariate for post-
fresh locomotion score and BCS analyses. Additional 
covariates included in the analyses for first-service 
conception, pregnancy by 150 DIM, and days open for 
cows pregnant by 150 DIM included DIM at the first 
breeding, AI synchronization status (synchronized = 
1; not synchronized = 0), and first breeding month. 
Categorical covariates were compressed into combined 
categories as needed to avoid missing combinations 
of covariates and to make the standard errors as 
equivalent as possible across group means. Continu-
ous covariates were plotted against study outcomes, 
and the resulting plots were inspected for evidence 
of breakpoints in the relationship along the spectrum 
of values for the continuous covariates. No logical 
breakpoints were apparent, so no continuous covari-
ates were compressed into categorical variables for the 
initial evaluations.
Statistical Analysis
Descriptive statistics were generated with the 
MEANS and FREQ procedures of SAS 9.3 (SAS Insti-
tute Inc., Cary, NC). Continuous study outcomes (Ca2+ 
8 to 35 h after calving, first-test milk yield, sum of 
health events in the first 30 DIM, postfresh locomotion 
score, postfresh BCS, and days open for cows pregnant 
by 150 DIM) were analyzed using multivariate linear 
regression with the MIXED procedure of SAS. Study 
outcomes with a binary response (metritis, ketosis, dis-
placed abomasum, mastitis, pneumonia, herd removal, 
death, first-service conception, and pregnant by 150 
DIM) were analyzed using a mixed-effects multivari-
ate Poisson regression with the GENMOD procedure 
of SAS (Frome and Checkoway, 1985; Spiegelman and 
Hertzmark, 2005). Poisson regression has the advan-
tage of directly estimating disease rates and relative 
risk, which is the most intuitive approach to modeling 
and presenting these data (Ospina et al., 2012).
Large models for the analysis of pregnancy status 
through 305 DIM were conducted using a semipara-
metric proportional hazards model (Cox, 1972) in the 
PHREG procedure of SAS. The time series variable 
for the model was the number of days from the end 
of the VWP (65 d for herd A and 78 d for herd B) 
until conception or censoring. Cows were dropped from 
the survival analysis (uninformative censoring) when 
they were removed from the herd (either sold or died) 
or declared ineligible for additional breedings (“do not 
breed” designation in the herd records). A small num-
ber of cows (n = 23) were still open and eligible for 
additional breedings by 305 DIM.
The effect of blanket supplementation with 2 oral Ca 
boluses for all study cows was evaluated using a 2-step 
statistical method. The method was the same whether 
the outcome was continuous or categorical (using mul-
tivariate linear regression), binary (using multivariate 
Poisson regression), or pregnancy status by 305 DIM 
(using survival analyses). First, a large model for each 
study outcome was fitted using every potential covari-
ate applicable to that outcome, plus the interactions 
of each covariate with oral Ca bolus supplementation 
and with herd. The specific terms available to the large 
models were herd (as a fixed effect), oral Ca bolus 
supplementation, lactation group (second, third, or 
fourth and greater), prefresh lameness status (0 if a 
locomotion score 1 or 2, 1 if a locomotion score 3 or 4), 
prefresh BCS (≤2.75, 3.00, 3.25, 3.50, 3.75, or ≥4.00), 
twin (0 if single birth, 1 if twin birth), stillbirth (0 if 
live calf or calves, 1 if 1 or 2 calves born dead), calving 
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ease score category (1 if ease score of 1, 2 if ease score 
of 2, 3 if ease score of 3 or 4), calving month (June, 
July, or August), previous lactation mature-equivalent 
milk production (expressed as percentage rank within 
herd—the values for all cows in each herd were ranked 
from lowest to highest and then assigned a percentage 
rank, with a value of 100% representing the average 
mature-equivalent milk production in the herd at that 
time), previous lactation length (days), previous lacta-
tion days dry, and previous lactation gestation length 
(days). Days in milk at first breeding, AI synchroniza-
tion status (synchronized = 1; not synchronized = 0), 
and first breeding month (instead of calving month) 
were included in the analyses for first-service concep-
tion, pregnancy by 150 DIM, and days open for cows 
pregnant by 150 DIM. The interactions between all 
variables and herd, plus all interactions between these 
variables and oral Ca bolus supplementation were also 
eligible for inclusion in the large models. Terms were re-
moved from the models in a stepwise, backward fashion 
until all were P < 0.05 in the model. Single variables 
were removed from the model only after no interaction 
terms were including that variable remaining in the 
model.
Survival analysis of pregnancy status by 305 DIM 
required the additional step of testing the reduced large 
model to determine if the assumption of proportional 
hazards was valid. This was done by including time-de-
pendent covariates (log-transformed days since VWP) 
in the large model (Allison, 1995). Because the time-
dependent covariates were significant, time-dependent 
covariates for every variable (plus their interactions) 
were made available and the model with the extra terms 
was reduced again by stepwise, backward elimination.
The purpose of the large models was to establish 
whether an effect of oral Ca bolus supplementation 
existed after all possible covariates (and interactions) 
had been considered. However, the large models were 
not useful for determining effect sizes. Almost all the 
large models contained continuous covariates after the 
backward elimination procedure, and least squares 
means calculated from such models are specific to a 
discrete value for each continuous covariate in the 
model. Many of the models contained 3 or 4 continuous 
covariates, which rendered it impractical to estimate 
the oral Ca bolus effect at every possible combination 
of these covariates. Therefore, a second analysis was 
conducted for each study outcome by using small mod-
els that consisted of herd (as a fixed effect), oral Ca 
bolus supplementation, and the interaction of herd and 
oral Ca bolus supplementation. The interaction term 
was removed if P < 0.05. Because the small models 
contained no continuous covariates, they were used to 
determine the estimates of effect sizes.
The effect of the oral Ca boluses was considered 
significant for an outcome only if oral Ca bolus supple-
mentation was P < 0.05 in both the large and small 
models for that outcome. Because no continuous co-
variates were present in the small models, overall least 
squares means could be calculated for control versus 
oral Ca bolus-supplemented cows. Least squares means 
and P-values from the small models were then reported 
for each outcome.
For the pregnancy status by 305 DIM survival analy-
sis, the small model consisted of a Kaplan-Meier analy-
sis (Kaplan and Meier, 1958) using the LIFETEST 
procedure of SAS. The model included oral Ca bolus 
supplementation and days from the end of VWP. From 
this procedure, the effect size of oral Ca supplementa-
tion was evaluated by calculating mean days from the 
end of the VWP until conception for both groups. Days 
open could be estimated by adding the average VWP 
to the mean value for days from the end of the VWP 
until conception.
After all the large and small models were completed 
and the effects of blanket supplementation for all cows 
were evaluated, the large models were examined to find 
interactions (P < 0.05) between oral Ca bolus supple-
mentation and any covariate. These interactions were 
the starting point for determining whether subpopula-
tions of cows responded differently to oral Ca bolus 
supplementation. When such interactions were found 
for a continuous covariate, a cut point was derived after 
visual inspection of a plot of the covariate versus the 
outcome, and the covariate was dichotomized based on 
this cut point. The dichotomized covariate was then 
reevaluated in a large model as a binary outcome. If the 
interaction of oral Ca bolus supplementation with the 
dichotomized covariate remained P < 0.05 (or if the in-
teraction with any binary covariate was P < 0.05), then 
the interaction was evaluated in a small model that 
contained only oral Ca bolus supplementation, herd, 
the covariate of interest, the interaction of this covari-
ate with oral Ca bolus supplementation, the interaction 
of this covariate with herd, and the interaction of herd 
with oral Ca bolus supplementation. Interaction terms 
with herd were removed from the model if P > 0.05. 
Least squares means were computed for the oral Ca 
bolus-supplemented versus control cows.
Two interactions with oral Ca bolus supplementa-
tion were significant at every evaluation point in the 
analyses described above. Specifically, they were 1) the 
interaction between prefresh lameness and oral Ca bo-
lus supplementation for the sum of health events before 
30 DIM and 2) previous lactation mature-equivalent 
milk production and oral Ca bolus supplementation for 
milk production at the first DHI test. Because some 
cows would be represented in both subpopulations and 
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because the most practical application of these results 
would be to target both subpopulations together for 
oral Ca bolus supplementation, the 2 covariates were 
combined into a single covariate. The analyses de-
scribed above (large models followed by small models) 
were then repeated using the new, combined covari-
ate as though it were a single covariate. Results were 
interpreted by evaluating the interaction between the 
combined covariate and oral Ca bolus supplementation. 
Least squares means were then reported for the com-
bined subpopulation of cows that would be targeted for 
oral Ca bolus supplementation.
Residual versus predicted value plots from analysis 
of the continuous outcomes were visually evaluated as 
a test for the assumption of normal distribution of the 
data. Heteroscedasticity or atypical distribution did 
not appear. Significance was claimed at P < 0.05 unless 
otherwise stated.
RESULTS AND DISCUSSION
Table 3 presents continuous outcomes and covariates 
by herd, and Table 4 presents binary outcomes and 
covariates by herd. Only 6 cows (0.6%) were treated 
for clinical milk fever during the study, and only 14.2% 
of cows had hypocalcemia (blood Ca2+ ≤1.00 mmol/L) 
when evaluated at 8 to 35 h postcalving. These results 
are extremely low compared with previously published 
data (DeGaris and Lean, 2008; Reinhardt et al., 2011) 
and indicate excellent overall effectiveness of the an-
ionic salt feeding program that was in place for both 
herds.
The study was conducted only in the summer months; 
however, it is unlikely that the low observed incidence 
of hypocalcemia was a seasonal effect. Østergaard et al. 
(2003) attempted to find published evidence for sea-
sonality of clinical milk fever but was unsuccessful. An 
evaluation of calvings and cases of clinical milk fever 
from 6 yr of data in the Dairy Comp 305 archives for 
both study herds (80 cases of milk fever and 18,887 
fresh events for cows in their second lactation and 
greater) revealed no difference between the risk of milk 
fever for cows calving in the summer months compared 
with cows that calved any other time of the year (rela-
tive risk of milk fever with summer calvings was 0.63, 
with a 95% confidence interval of 0.36 to 1.13).
Oral Ca bolus supplementation did not affect (P > 
0.05) any study outcomes when all study cows were 
considered together. This result was expected, given 
the very low incidence of hypocalcemia during the 
study period. Melendez et al. (2002) also gave oral Ca 
supplements to multiparous cows fed a low DCAD diet 
and found no effect of these supplements on plasma 
concentrations of total Ca, P, Mg, NEFA, BHBA, or 
glucose.
No effect of oral Ca bolus supplementation was 
observed on days from the end of the VWP to con-
ception in the large survival model (data not shown) 
or in the small survival models. Kaplan-Meier curves 
from the small models are presented in Figure 1 (data 
from all cows) and Figure 2 (data from cows in the 
subpopulation targeted for oral Ca bolus supplementa-
tion). Hernandez et al. (1999) also reported no effect 
of oral Ca supplementation on first-service conception; 
Table 3. Summary of continuous and categorical study outcomes and covariates by herd; data are from 927 cows in their second lactation and 
greater in 2 commercial dairies 
Item
Herd A Herd B
n Mean ± SEM n Mean ± SEM
Continuous or categorical outcome
 Ca2+ at 8 to 35 h postcalving, mmol/L 318 1.13 ± 0.01  525 1.16 ± 0.01
 First-test milk yield, kg 364 44.4 ± 0.6  527 37.2 ± 0.5
 Sum of health events1 ≤30 DIM 372 0.59 ± 0.04  555 1.01 ± 0.04
 Postfresh locomotion score, 1 to 4 scale 324 1.79 ± 0.04  466 1.71 ± 0.03
 Postfresh BCS, 1 to 5 scale 325 2.51 ± 0.02  466 2.56 ± 0.02
 Days open for cows pregnant by 150 DIM 207 90.4 ± 1.7  298 99.5 ± 1.2
Continuous or categorical covariate      
 Lactation number 372 2.79 ± 0.05  555 3.05 ± 0.04
 Previous lactation length, d 371 361.0 ± 4.1  554 353.1 ± 3.1
 Previous gestation length, d 372 277.6 ± 0.3  555 277.4 ± 0.2
 Previous lactation 305-d mature-equivalent milk yield, % rank within herd 371 100.6 ± 0.8  554 99.7 ± 0.7
 Previous days dry 372 48.6 ± 0.8  555 58.8 ± 1.0
 Prefresh locomotion score, 1 to 4 scale 366 1.60 ± 0.04  532 1.63 ± 0.03
 Prefresh BCS, 1 to 5 scale 364 3.18 ± 0.02  529 3.26 ± 0.02
 Calving ease score, 1 to 5 scale 372 1.19 ± 0.03  555 1.28 ± 0.03
 DIM at first test 364 19.4 ± 0.5  527 19.4 ± 0.4
 DIM at first breeding 332 73.5 ± 0.3  409 84.3 ± 0.2
1Health events included were metritis, ketosis, displaced abomasum, mastitis, pneumonia, herd removal, or death (only for events in the first 
30 DIM).
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Table 4. Summary of binary study outcomes and covariates by herd; data are from 927 cows in their second 
lactation and greater in 2 commercial dairies 
Item
Herd A Herd B
11 02 Cows, % 1 0 Cows, %
Binary outcome        
 Clinical milk fever 0 372 0.0  6 549 1.1
 Hypocalcemia3 55 263 17.3  65 460 12.4
 Retained placenta 30 342 8.1  63 492 11.4
 Metritis ≤14 DIM 52 320 14.0  103 452 18.6
 Ketosis4 ≤16 DIM 98 84 53.8  284 158 64.3
 Displaced abomasum ≤30 DIM 12 360 3.2  31 524 5.6
 Mastitis ≤30 DIM 38 334 10.2  76 479 13.7
 Pneumonia ≤30 DIM 5 367 1.3  22 533 4.0
 Herd removal ≤30 DIM 14 358 3.8  44 511 7.9
 Died ≤30 DIM 5 367 1.3  18 537 3.2
 First-service conception 129 203 38.9  172 237 42.1
 Pregnant by 150 DIM 207 104 66.6  298 118 71.6
Binary covariate        
 Twin calves 26 346 7.0  46 509 8.3
 Stillborn (1 or more calves dead) 11 361 3.0  24 531 4.3
 Prefresh lameness5 41 325 11.2  63 469 11.8
11 = count of cows with the condition.
20 = count of cows without the condition.
3Hypocalcemia was defined as blood Ca2+ ≤1.00 mmol/L at 8 to 35 h after calving.
4Ketosis was defined as 1 or more blood BHBA tests ≥1.2 mmol/L. Cows were tested 6 times between 3 and 
16 DIM and were classified if they had ≥5 total BHBA tests or ≥1 positive test.
5Lame cows had a prefresh locomotion score of 3 or 4, using a 1- to 4-point scale.
Figure 1. Kaplan-Meier plot for the effect of oral Ca bolus supplementation on pregnancy to 305 DIM. Oral Ca bolus-supplemented cows 
received 2 boluses (Bovikalc, Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO) after calving. Control cows were not supplemented with 
oral Ca boluses. Data are from 638 cows in their second lactation and greater in 2 commercial dairies that were eligible to be bred at the end 
of the voluntary waiting period.
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however, this was a small study that enrolled cows only 
with retained fetal membranes. Chapinal et al. (2012) 
reported that cows with low serum Ca either the week 
before or the week after calving had reduced odds for 
conceiving at first service. The authors did not evaluate 
reproductive performance beyond the first service.
Two variables had significant interactions with oral 
Ca bolus supplementation that were present throughout 
the process of evaluating the large and small models. 
The first was the interaction between oral Ca bolus 
supplementation and prefresh lameness (locomotion 
score 3 or 4) for the sum of health events by 30 DIM 
(Table 5; P = 0.005). The other variable to have a 
significant interaction with oral Ca bolus supplemen-
tation was previous lactation mature-equivalent milk 
production rank with first-test milk yield (Table 6; P = 
0.015). Prefresh lameness had a significant interaction 
with first-test milk yield in the large model; however, 
this interaction was not significant in the small model.
Using the small models, we calculated least squares 
means for oral Ca bolus-supplemented and control cows 
for first-test milk yield across a range of values for pre-
vious lactation milk yield. These least squares means 
were then plotted (Figure 3). Based on an evaluation 
of this plot, cut points between 100 and 115 previous 
lactation milk yield percentage rank were considered. 
These cut points were evaluated for their effect on both 
first test milk yield and the sum of health events in 
early lactation. The cut point was kept as low as pos-
sible to maximize the number of cows that could ben-
efit from oral Ca bolus supplementation, still preserve 
a significant increase in milk yield, and not increase the 
number of health events before 30 DIM. A cut point of 
>105% of herd rank was the lowest cut point at which 
oral Ca bolus supplementation significantly increased 
milk yield without impairing health.
A new analysis was then conducted, starting with a 
new stepwise, backward elimination in the large model, 
to determine how the new dichotomous variable (previ-
ous lactation mature-equivalent milk yield >105% or 
≤105% of herd rank) affected oral Ca bolus response. 
Cows above the cut point had significantly (P = 0.024) 
increased milk yield when supplemented with the oral 
Ca bolus compared with cows above the cut point that 
were not supplemented. This dichotomized variable 
was then included in a final, small model. The response 
to oral Ca bolus supplementation in cows with a high 
previous lactation milk yield was +2.9 kg of milk at the 
Figure 2. Kaplan-Meier plot for the effect of oral Ca bolus supplementation on pregnancy to 305 DIM. Oral Ca bolus-supplemented cows 
received 2 boluses (Bovikalc, Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO) after calving. Control cows were not supplemented with 
oral Ca boluses. Data are from 313 cows in their second lactation and greater in 2 commercial dairies that were eligible to be bred at the end of 
the voluntary waiting period and were in the subpopulation targeted for oral Ca bolus supplementation (previous lactation mature-equivalent 
milk production >105% of herd average at calving or prefresh lameness, or both).
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first DHI test after calving (P = 0.009; Table 7). This 
increase in milk yield (7.2%) was of greater magnitude 
than the 3.6% increase in milk yield reported for cows 
supplemented with anionic salts (Beede et al., 1992). 
The inclusion of first-lactation animals in the analysis 
of Beede et al. (1992) could explain a portion of the 
lower overall milk production response. Smaller scale 
studies have shown no effect of oral Ca supplementation 
on subsequent milk yield (Goff et al., 1996; Dhiman 
and Sasidharan, 1999; Melendez et al., 2002); these 
studies did not attempt to identify subpopulations of 
cows that might have a different response to oral Ca 
supplementation.
Although a significant interaction was observed be-
tween oral Ca bolus supplementation and lameness for 
the sum of early-lactation health events, no significant 
effect of oral Ca bolus supplementation was observed for 
any of the individual disease or reproductive outcomes 
(Table 8). Oetzel (1996) reported a decreased incidence 
of displaced abomasum after oral Ca administration 
around calving; however, the underlying incidence of 
hypocalcemia (53%) was much greater in this study 
Table 5. Estimates and type 3 tests of fixed effects from a reduced mixed regression model for the sum of health events1 in the first 30 DIM2 
Effect and effect level Estimate SE Numerator df Denominator df P-value3
Intercept 1.292 0.289 — — <0.001
Oral Ca bolus supplementation   1 867 0.120
 Control (no oral Ca boluses) 0.368 0.159
 Supplemented (2 oral Ca boluses given) —4 —4
Herd   1 867 0.002
 Herd A −0.406 0.322
 Herd B —4 —4
Lactation group   2 867 0.032
 Lactation = 2 −0.170 0.068
 Lactation = 3 −0.051 0.073
 Lactation ≥4 —4 —4
Prefresh lameness   1 867 0.046
 Not lame (locomotion score 1 or 2) 0.064 0.121
 Lame (locomotion score 3 or 4) —4 —4
Prefresh BCS   4 867 0.382
 ≤2.75 BCS 0.006 0.149
 3.00 BCS 0.163 0.133
 3.25 BCS 0.033 0.121
 3.50 BCS 0.167 0.128
 ≥3.75 BCS —4 —4
Calving month   2 867 <0.001
 June —4 —4
 July 0.037 0.070
 August −0.276 0.072
Previous lactation milk yield,5 % rank within herd −0.005 0.002 1 867 0.003
Previous lactation length, d 0.0003 0.0005 1 867 0.005
Previous dry period length, d 0.004 0.001 1 867 0.009
Herd × previous lactation length   1 867 0.049
 Herd A and previous lactation length 0.0014 0.0007
 Herd B and previous lactation length —4 —4
Herd × prefresh BCS   4 867 0.021
 Herd A and ≤2.75 BCS −0.464 0.230
 Herd A and 3.00 BCS −0.689 0.212
 Herd A and 3.25 BCS −0.416 0.203
 Herd A and 3.50 BCS −0.573 0.218
 All other combinations —4 —4
Oral Ca bolus × prefresh lameness   1 867 0.005
 No oral Ca boluses and not lame −0.474 0.169
 All other combinations —4 —4
1Health events included were metritis, ketosis, displaced abomasum, mastitis, pneumonia, herd removal, or death (only for events in the first 
30 DIM).
2All possible covariates plus interactions with herd and oral Ca bolus supplementation (Bovikalc, Boehringer Ingelheim Vetmedica Inc., St. 
Joseph, MO) were considered and removed by backward elimination until P < 0.05 in the model. Cows in the oral Ca bolus group received 2 
oral Ca boluses (1 bolus at calving and 1 bolus 8 to 35 h after calving). Data are from 927 cows in their second lactation and greater in 2 com-
mercial dairies. 
3Except for the intercept, P-values reported are the type 3 test of fixed effects for the entire variable.
4Reference group.
5The 305-d mature-equivalent milk production; 100% represented the average cow in the herd at the time the cow calved.
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compared with 14% in the current one. Melendez et 
al. (2002) and Dhiman and Sasidharan (1999) reported 
no effect of oral Ca supplementation around calving on 
later concentrations of BHBA, and Goff et al. (1996) 
reported no effect of oral Ca supplementation on rates 
of primary ketosis. These findings are in agreement 
with the current study, which demonstrated no effect of 
oral Ca supplementation on the incidence of cows with 
blood BHBA ≥1.2 mmol/L.
No other variables had a significant interaction 
with oral Ca bolus supplementation. Thus, the final 
target group for oral Ca bolus supplementation was 
cows that were lame in the prefresh period and cows 
with higher previous lactation mature-equivalent milk 
production (>105% of herd rank). Lame cows and cows 
with higher previous milk production were combined 
and designated with a single new binary variable in the 
data set. This subpopulation represented 444 cows, or 
Table 6. Type 3 tests of fixed effects from a reduced mixed regression model for first-test milk yield (kg/cow per day)1 
Effect and effect level Estimate SE Numerator df Denominator df P-value2
Intercept −2.00 22.52 — — 0.929
Oral Ca bolus supplementation   1 831 0.057
 Control (no oral Ca boluses) 5.42 4.14
 Supplemented (2 oral Ca boluses given) —3 —3
Herd   1 831 0.045
 Herd A −73.39 34.54
 Herd B —3 —3
Prefresh lameness   1 831 0.478
 Not lame (locomotion score 1 or 2) −1.30 1.40
 Lame (locomotion score 3 or 4) —3 —3
Prefresh BCS   4 831 0.337
 ≤2.75 BCS −3.41 1.70
 3.00 BCS −3.84 1.48
 3.25 BCS −2.42 1.37
 3.50 BCS −2.54 1.47
 ≥3.75 BCS —3 —3
Calving month   2 831 0.271
 June —3 —3
 July 1.42 1.06
 August 0.24 1.06
Previous lactation milk yield,4 % rank within herd 0.260 0.029 1 831 <0.001
Previous lactation length, d −0.0095 0.0041 1 831 0.023
Previous gestation length, d 0.040 0.081 1 831 0.005
DIM at first test 0.449 0.033 1 831 <0.001
Herd × previous gestation length   1 831 0.028
 Herd A and previous gestation length 0.275 0.125
 Herd B and previous gestation length —3 —3
Herd × calving month   2 831 0.003
 Herd A and July calving month −3.77 1.67
 Herd A and August calving month 0.94 1.64
 All other combinations —3 —3
Herd × prefresh BCS   4 831 0.028
 Herd A and ≤2.75 BCS 5.01 2.63
 Herd A and 3.00 BCS 7.17 2.41
 Herd A and 3.25 BCS 6.80 2.30
 Herd A and 3.50 BCS 4.50 2.48
 All other combinations —3 —3
Oral Ca bolus × previous lactation milk yield   1 831 0.015
 No oral Ca boluses and previous milk yield −0.092 0.038
 Oral Ca boluses and previous milk yield —3 —3
Oral Ca bolus × prefresh lameness   1 831 0.042
 No oral Ca bolus and not lame 4.00 1.97
 All other combinations —3 —3
1All possible covariates plus interactions with herd and oral Ca bolus (Bovikalc, Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO) supple-
mentation were considered and removed by backward elimination until P < 0.05 in the model. Cows in the oral Ca bolus group received 2 oral 
Ca boluses (1 bolus at calving and 1 bolus 8 to 35 h after calving). Data are from 927 cows in their second lactation and greater in 2 commercial 
dairies. Health events included were metritis, ketosis, displaced abomasum, mastitis, pneumonia, herd removal, or death (only for events in the 
first 30 DIM). 
2Except for the intercept, P-values reported are the type 3 test of fixed effects for the entire variable.
3Reference group.
4The 305-d mature-equivalent milk production; 100% represented the average cow in the herd at the time the cow calved.
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about 48% of the eligible cows. After combining the 2 
targeted groups, the same analyses using the smaller 
models were done for all outcomes, this time looking 
at the interaction between oral Ca bolus and the new 
variable that represented the combined subpopulations. 
These results are reported in Tables 7 and 8. The com-
bined lame cows and cows with high previous lactation 
milk production gave 3.1 kg more milk (P = 0.002) 
compared with the control cows. This same group 
of cows had 0.04 fewer health events in the first 30 
DIM. This difference was not significant (P = 0.628), 
although it is noteworthy that cows supplemented with 
oral Ca boluses gave more milk without a concomitant 
increase in health events. The size of the milk yield 
increase after oral Ca bolus supplementation to the tar-
geted subpopulation of cows in the current study was 
very similar to the early-lactation milk yield losses of 
3.2 kg/d for cows with serum Ca ≤2.1 mmol/L during 
wk −1 relative to calving and 4.8 kg/d for cows with 
serum Ca ≤2.1 mmol/L during wk +1 relative to calv-
ing reported by Chapinal et al. (2012).
Oral Ca bolus supplementation did not improve Ca2+ 
concentrations in the sample collected at 8 to 35 h after 
calving (P = 0.271). The timing of the collection of 
the Ca2+ sample (20.6 h after administration of the 
first bolus, and immediately before the administration 
of the second bolus) was such that an effect of oral 
Ca supplementation was not expected. Sampson et al. 
(2009) reported that oral Ca boluses increased blood 
Ca2+ concentrations at only 2 time points—1 h after 
administration of both the first oral Ca bolus (given 
at calving) and 1 h after administration of the second 
bolus (given 12 h after calving). Sampson et al. (2009) 
also reported a significant decrease in urinary pH at 
24 h after calving, which could explain more prolonged 
benefits to oral Ca bolus administration beyond the 
short time period of increased blood Ca2+.
It was not feasible in the current study to document 
blood Ca2+ changes soon after the second bolus was 
administered because the cows could be restrained in 
headlocks only once daily and were restrained for the 
shortest time possible at each lockup. Ramos-Nieves 
et al. (2009) reported that cows had the highest pro-
portion of subclinical hypocalcemia about 16 h after 
calving, which is close to the mean time (20.6 h post-
calving) that the second bolus was administered in the 
current study.
The mechanism for the beneficial effect of oral Ca 
bolus supplementation cannot be determined from 
the results of this study. Lame cows could be prone 
Figure 3. Interaction between oral Ca bolus supplementation and previous lactation mature-equivalent milk yield (expressed as percentage 
rank within herd) for first-test milk yield after calving. Oral Ca bolus-supplemented cows received 2 boluses (Bovikalc, Boehringer Ingelheim 
Vetmedica Inc., St. Joseph, MO) after calving. Control cows were not supplemented with oral Ca boluses. Data are from 927 cows in their second 
lactation and greater in 2 commercial dairies.
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to injury after calving, especially if they are weakened 
by hypocalcemia. Transient correction of hypocalcemia 
could prevent injury and decrease the total number of 
health events in lame cows. Stimulation of additional 
DMI after correction of transient hypocalcemia is a 
plausible explanation for the increased milk yield. This 
explanation is consistent with the observation that 
feeding low DCAD diets before calving was associated 
with higher DMI in early lactation (Eppard et al., 1996; 
Joyce et al., 1997). However, DMI in individual cows 
was not measured in the current study.
Heuer et al. (1999) reported that overconditioned 
cows are at increased risk of hypocalcemia. However, 
prefresh BCS did not have a significant interaction with 
oral Ca bolus supplementation in the current study. 
The number of overly conditioned animals (BCS ≥4.00) 
was only about 4% for the 2 study herds.
Increasing lactation number has been associated with 
increased risk of hypocalcemia (Reinhardt et al., 2011). 
However, parity did not have a significant interaction 
with oral Ca bolus supplementation in the current 
study. This finding suggests that oral Ca supplementa-
tion should not be restricted to very old (e.g., lactation 
3 or greater) cows only.
Results of this study did not reveal any detrimen-
tal effects of providing additional anions (in this case, 
chloride and sulfate anions from the oral Ca boluses) 
to cows that had received a low DCAD diet before 
calving. This was not surprising, considering that cows 
have lowered feed intake on the day of calving and are 
typically switched from the low DCAD diet soon after 
calving. Cows in the current study were all consuming a 
higher DCAD (lactating) diet when they received their 
second oral Ca bolus. It appeared that the benefits of 
the additional acidification from oral Ca bolus adminis-
tration (Sampson et al., 2009) caused more benefits via 
improved Ca metabolism than potentially detrimental 
effects from systemic acidification. Supporting higher 
Table 7. Least squares means for cows supplemented with an oral Ca bolus1 or control cows (no oral Ca bolus supplementation) for continuous 
or categorical study outcomes from 927 cows in their second lactation and greater in 2 commercial dairies2 
Outcome
Oral Ca bolus Control
Difference3 P-value4n
Least squares  
mean ± SE n
Least squares  
mean ± SE
Ionized Ca, 8 to 35 h postcalving, mmol/L
 All cows 418 1.15 ± 0.01  425 1.14 ± 0.01 0.01 0.271
 Lame5 or previous milk >105%6 199 1.15 ± 0.01  209 1.12 ± 0.01 0.02 0.123
First-test milk yield, kg
 All cows 412 41.1 ± 0.5  497 40.5 ± 0.5 0.6 0.404
 Previous milk >105% 168 46.1 ± 0.8  244 43.3 ± 0.7 2.9 0.009
 Lame or previous milk >105% 198 45.2 ± 0.7  233 42.2 ± 0.7 3.1 0.002
Sum of health events ≤30 DIM
 All cows 431 0.84 ± 0.04  496 0.76 ± 0.04 0.07 0.182
 Lame 52 0.89 ± 0.12  51 1.23 ± 0.12 −0.34 0.040
 Lame or previous milk >105% 204 0.72 ± 0.06  238 0.76 ± 0.05 −0.04 0.628
Postfresh locomotion score
 All cows 381 1.74 ± 0.04  409 1.82 ± 0.05 −0.06 0.256
 Lame or previous milk >105% 187 1.78 ± 0.06  202 1.82 ± 0.05 −0.04 0.776
Postfresh BCS
 All cows 381 2.49 ± 0.02  410 2.57 ± 0.02 −0.08 0.0897
 Lame or previous milk >105% 187 2.46 ± 0.03  202 2.48 ± 0.03 −0.01 0.756
Days open for cows pregnant by 150 DIM
 All cows 239 96.6 ± 1.5  266 93.5 ± 3.1 2.0 0.124
 Lame or previous milk >105% 119 99.8 ± 2.1  124 93.0 ± 2.0 6.8 0.053
Days from VWP to conception for cows to 305 DIM8
 All cows 295 70.9 ± 4.2  343 68.8 ± 3.7 2.1 0.930
 Lame or previous milk >105% 146 69.0 ± 5.4  167 68.0 ± 5.1 0.9 0.796
1Cows in the supplemented group received 2 oral Ca boluses (Bovikalc, Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO; 1 bolus at calv-
ing and 1 bolus 8 to 35 h after calving).
2Results are from small models that included oral Ca bolus supplementation, herd, and their interaction (if P < 0.05 for the interaction term).
3Difference in least squares means, oral Ca bolus − control.
4For interaction terms, P is the higher of the specific comparison or the interaction term.
5Lame cows had a prefresh locomotion score of 3 or 4, using a 1- to 4-point scale.
6Previous lactation mature-equivalent milk yield, % of herd rank.
7The P-value for postfresh BCS is from the large model, which was P > 0.05 and was greater than the P-value from the small model.
8Estimate of mean days from the end of the voluntary waiting period (VWP) to pregnancy using Kaplan-Meier analysis. The mean voluntary 
waiting period was 72.5 d for all cows and 72.7 d for cows in the subpopulation targeted for oral Ca bolus supplementation.
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blood Ca concentrations during the critical first 2 d 
after calving may be of primary importance to multipa-
rous cows.
CONCLUSIONS
Supplementing all cows in their second lactation and 
greater with 2 oral Ca boluses in herds with very effec-
tive programs of feeding anionic salts neither harmed 
nor benefited early-lactation health or milk yield. Cows 
that were lame before calving and were supplemented 
with oral Ca boluses had improved early-lactation 
health compared with lame cows that were not supple-
mented. Cows that had high previous lactation mature-
equivalent milk production and were supplemented 
with oral Ca boluses had increased early-lactation milk 
yield compared with high-producing cows that were not 
supplemented. This subpopulation of lame and higher 
producing cows represented 48% of the multiparous cows 
in the 2 study herds. Supplementation of the combined 
subpopulation of cows with oral Ca boluses resulted in 
increased milk yield without affecting early-lactation 
health. These results indicate that dairy herds already 
experiencing a very low incidence of hypocalcemia can 
target a subpopulation of cows that will respond favor-
ably to supplementation with oral Ca boluses.
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Table 8. Least squares means for cows supplemented with an oral Ca bolus1 or control cows with no oral Ca bolus supplementation for binary 
outcomes (health events ≤30 DIM and reproductive outcomes) from 927 cows in their second lactation and greater in 2 commercial dairies2 
Outcome
Oral Ca bolus1 Control Oral Ca versus control
P-value3n Risk, % n Risk, % Risk ratio 95% CI
Metritis, %          
 All cows 431 17.2  496 15.2  1.13 0.85 to 1.51 0.394
 Lame4 or previous milk >105%5 206 14.0  238 14.9  0.94 0.61 to 1.47 0.794
Ketosis,6 %          
 All cows 290 60.5  334 57.4  1.40 0.93 to 1.19 0.422
 Lame or previous milk >105% 129 55.7  165 54.2  1.03 0.85 to 1.25 0.834
Displaced abomasum, %          
 All cows 431 4.4  496 4.1  1.09 0.61 to 1.96 0.764
 Lame or previous milk >105% 206 4.0  238 5.0  0.81 0.35 to 1.87 0.619
Mastitis, %          
 All cows 431 12.9  496 10.6  1.22 0.84 to 1.77 0.297
 Lame or previous milk >105% 206 13.7  238 9.8  1.39 0.83 to 2.34 0.512
Pneumonia, %          
 All cows 431 2.2  496 2.4  0.91 0.43 to 1.93 0.813
 Lame or previous milk >105% 206 1.2  238 3.6  0.32 0.09 to 1.11 0.073
Removal from the herd %          
 All cows 431 6.5  496 4.6  1.41 0.85 to 2.33 0.182
 Lame or previous milk >105% 206 5.1  238 4.3  1.17 0.54 to 2.55 0.686
Died, %          
 All cows 431 2.7  496 1.5  1.78 0.79 to 4.02 0.167
 Lame or previous milk >105% 206 2.5  238 1.4  1.76 0.52 to 6.04 0.877
First-service conception, %          
 All cows 343 38.6  398 42.0  0.92 0.77 to 1.10 0.347
 Lame or previous milk >105% 168 33.8  193 39.6  0.85 0.65 to 1.11 0.434
Pregnancy by 150 DIM, %          
 All cows 337 70.5  390 67.8  1.04 0.95 to 1.15 0.416
 Lame or previous milk >105% 164 72.1  186 66.1  1.09 0.95 to 1.26 0.391
1Cows in the supplemented group received 2 oral Ca boluses (Bovikalc, Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO; 1 bolus at calv-
ing and 1 bolus 8 to 35 h after calving).
2Results are from small models that included oral Ca bolus supplementation, herd, and their interaction (if P < 0.05 for the interaction term).
3For interaction terms, P is the higher of the specific comparison or the interaction term.
4Lame cows had a prefresh locomotion score of 3 or 4, using a 1- to 4-point scale.
5Previous lactation mature-equivalent milk production, % of herd rank.
6Ketosis was defined as 1 or more blood BHBA tests ≥1.2 mmol/L. Cows were tested 6 times between 3 and 16 DIM and were classified if they 
had ≥5 total BHBA tests or ≥1 positive test.
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tal design and statistical analysis, and especially to the 
owners and employees of the collaborating dairies for 
administering the boluses, collecting the blood samples, 
and granting us access to their facilities, cows, and herd 
records.
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